US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 3.410
  • -0.160-4.48%
Close Jun 18 16:00 ET
388.17MMarket Cap-1776P/E (TTM)

Fate Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jun 17, 2024

Based on 15 analysts giving stock ratings to Fate Therapeutics in the past 3 months

Buy

  • Buy

    33.33%

  • Hold

    60.00%

  • Sell

    6.67%

Price Target

Updated: Jun 17, 2024

The average Fate Therapeutics stock price target is 6.54 with a max estimate of 10.00 and a min estimate of 5.00

Review Fate Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jun 17, 2024

Buy

  • Buy

    33.33%

  • Hold

    60.00%

  • Sell

    6.67%

Price Target

Updated: Jun 17, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg